Principal Financial Group’s Verona Pharma VRNA Stock Holding History

Principal Financial Group’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-21,364	Closed	-$2.28M	–	2276
2025 Q3	$2.28M	Hold	21,364	–	–	﹤0.01%	1795
2025 Q2	$2.02M	Buy	+21,364	New	+$1.58M	﹤0.01%	1803

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Principal Financial Group's VRNA Position: Q4 2025 in Review

Principal Financial Group sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 21,364 shares — an estimated $2.28M sold.

Principal Financial Group first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $2.28M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Principal Financial Group reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Principal Financial Group sold 21,364 Verona Pharma shares in Q4 2025, an estimated $2.28M.
Principal Financial Group first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
Principal Financial Group's Verona Pharma position peaked at $2.28M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Principal Financial Group's 13F filing for Q4 2025, filed 2 Feb 2026.